CD70 and primary cutaneous T-cell non-Hodgkin lymphoma: SGN-70A inhibited cell growth and induced higher caspase activity in CD70-positive cell lines of cutaneous T-cell lymphoma (CTCL) and patient-derived T-cell lymphoma primary cells.